Findings indicate that altering glucose metabolism in T cells boosts their therapeutic potential against melanoma, paving the ...
Financially, UroGen has a market cap of $464mn and a cash runway of 8-9 quarters, despite facing patent challenges from Teva. Despite promising data and market potential, UroGen's low market cap ...
Scientists mapped how the human immune system evolves from birth to old age, revealing key changes that influence health, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback